Neuronetics (STIM) Shares Outstanding (Diluted Average) (2019 - 2026)
Neuronetics has reported Shares Outstanding (Diluted Average) over the past 8 years, most recently at $69.6 million for Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 13.22% to $69.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $69.6 million through Mar 2026, up 13.22% year-over-year, with the annual reading at $66.0 million for FY2025, 107.82% up from the prior year.
- Shares Outstanding (Diluted Average) was $69.6 million for Q1 2026 at Neuronetics, up from $66.0 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $69.6 million in Q1 2026 and troughed at $26.6 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $29.5 million (2024), against an average of $39.4 million.
- Year-over-year, Shares Outstanding (Diluted Average) grew 2.52% in 2022 and then skyrocketed 124.88% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $26.9 million in 2022, then rose by 6.54% to $28.7 million in 2023, then rose by 10.73% to $31.7 million in 2024, then skyrocketed by 107.82% to $66.0 million in 2025, then grew by 5.52% to $69.6 million in 2026.
- Per Business Quant, the three most recent readings for STIM's Shares Outstanding (Diluted Average) are $69.6 million (Q1 2026), $66.0 million (Q4 2025), and $67.3 million (Q3 2025).